PHARMARISE HOLDINGS CORPORATION financial statements, including revenue, expenses, profit, and loss
The total revenue of 2796 for the last quarter is 15.31 B JPY, and it's 0.54% higher compared to the previous quarter. The net income of Q2 24 is 17.00 M JPY.